Regarding liver cancer in human patients, the most compelling information related to YAP is that approximately 50% of human HCC show aberrant overexpression and nuclear localization of YAP [51] and a small fraction of which is attributable to YAP gene amplification [50]. The gene discussed is YAP1; the disease is liver cancer.